ACARIX — Acarix AB Share News
0.000.00%
Last trade - 00:00- SEK236.94m
- SEK208.05m
- SEK7.36m
Brief: Acarix Signs Commercial Access Agreement With Proximo Medical
Brief: Acarix Decides On Fully Guaranteed Rights Issue
Brief: Acarix: Initial Dan-NICAD II Results Presented Today At ESC
Brief: Acarix Q2 Revenues Rises To SEK 878 Thousand
Brief: Acarix Q1 Loss Before Tax Widens To SEK 11.7 Mln
Brief: Acarix Q4 Pretax Loss Widens To SEK 11.4 Mln
Brief: Acarix Reports Positive Preliminary Data From SEISMO Study
Brief: Acarix: FDA Identifies Exclusive Code For The CADScor®
Brief: Acarix Gets US Market Approval For The Cadscor System
Brief: Acarix - Positive Results From Acarix Study Presented At Ispor
Brief: Acarix Q3 Loss Before Tax Narrows To SEK 8.9 Mln
Brief: Acarix Carries Out Directed Issue Of Shares To Guarantors
Brief: Acarix Announce Final Outcome In Oversubscribed Rights Issue
Brief: Acarix Announces Preliminary Outcome In Oversubscribed Rights Issue
Brief: Acarix Progresses With The German Authorities
Brief: Acarix Q2 Loss Before Tax Narrows To SEK 10.4 Mln
Brief: Acarix Decides On A Guaranteed Rights Issue
Brief: Acarix Q1 Pretax Loss Narrows To SEK 10.8 Million
Brief: Acarix Receives Feedback On German Reimbursement Submission